Palladium-catalyzed stereoselective decarboxylative allylation of azlactones: access to (<i>Z</i>)-trisubstituted allylic amino acid derivatives-Reference-Cited by-同舟云学术

Palladium-catalyzed stereoselective decarboxylative allylation of azlactones: access to (Z)-trisubstituted allylic amino acid derivatives

Published:2022 Issue:22 Volume:9 Page:6172-6178
ISSN:2052-4129
Container-title:Organic Chemistry Frontiers
language:en
Short-container-title:Org. Chem. Front.

Author:

Zhao Jian-Qiang¹^ORCID,Rao Han-Wen¹,Qian Hui-Ling¹,Zhang Xue-Man¹,Zhou Shun¹²,Zhang Yan-Ping¹,You Yong¹^ORCID,Wang Zhen-Hua¹^ORCID,Yuan Wei-Cheng¹^ORCID

Affiliation:

1. Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China

2. National Engineering Research Center of Chiral Drugs, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu, 610041, China

Abstract

A palladium-catalyzed stereoselective decarboxylative allylation of azlactones with vinyl methylene cyclic carbonates affords a series of trisubstituted allylic amino acid derivatives in good yields with an exclusive (Z)-configuration.

Funder

Sichuan Province Science and Technology Support Program

National Natural Science Foundation of China

Chengdu University

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/QO/D2QO01297A

Reference76 articles.

1. The lysine pathway as a target for a new genera of synthetic antibacterial antibiotics?